AI Enabled EEG Natus recently expanded AI-supported EEG interpretation with autoSCORE and expanded access across Europe and international markets, presenting a cross-border upsell path for upgraded software licenses and regional training services.

Elite EMG Expansion The launch of the newest version of Natus Elite EMG software in 2026 indicates a continuing product refresh cycle, creating opportunities for software renewal negotiations, bundled hardware-software deals, and added service contracts.

Neurodiagnostic Growth Acquisition activity in neurodiagnostics (Holberg EEG acquisition in 2025) signals a strategic push in AI-enabled neurodiagnostic solutions, implying cross-sell potential to existing Holberg customers and integration opportunities with Natus platforms.

Leadership & Strategy Board additions and executive hires in 2025–2026 (e.g., new board member and CCO appointment) suggest a focus on global sales expansion, commercial operations optimization, and potential partnerships or distribution channel enhancements.

Healthcare Market Fit With a mid-market revenue range and a portfolio spanning ICU monitoring, ICP/ED drainage, EEG, EMG, and PSG, there are sales angles for integrated neurocritical care solutions, bundled service offerings, and multi-site hospital deployments targeting mid-size to large health systems.